Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect

BACKGROUND: Some studies have indicated that a local injection of Botulinum Toxin Type A (BTX-A) is a promising therapy for trigeminal neuralgia (TN). However, BTX-A treatment is still ineffective for approximately 10–43% of patients. We therefore investigated which factors are associated with the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shouyi, Lian, Yajun, Zhang, Haifeng, Chen, Yuan, Wu, Chuanjie, Li, Shuang, Zheng, Yake, Wang, Yuhan, Cheng, Wenchao, Huang, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643497/
https://www.ncbi.nlm.nih.gov/pubmed/31410051
http://dx.doi.org/10.2147/JPR.S205467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643497/
https://www.ncbi.nlm.nih.gov/pubmed/31410051
http://dx.doi.org/10.2147/JPR.S205467

Ejemplares similares